Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
17.59
+0.31 (1.79%)
At close: Dec 20, 2024, 4:00 PM
17.20
-0.39 (-2.22%)
After-hours: Dec 20, 2024, 4:21 PM EST
Entrada Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Cash & Equivalents | 78.05 | 67.6 | 45.16 | 291.06 | 39.05 | 16.84 |
| Short-Term Investments | 371.3 | 284.37 | 143.56 | - | - | - |
| Cash & Short-Term Investments | 449.34 | 351.97 | 188.71 | 291.06 | 39.05 | 16.84 |
| Cash Growth | 27.08% | 86.51% | -35.16% | 645.46% | 131.80% | - |
| Accounts Receivable | 2.6 | 5.88 | - | - | - | - |
| Other Receivables | 1.2 | 1.7 | 0.6 | - | - | - |
| Receivables | 3.8 | 7.58 | 0.6 | - | - | - |
| Prepaid Expenses | 12.19 | 9.92 | 20.56 | 7.64 | 0.9 | 0.59 |
| Other Current Assets | - | 0.3 | - | - | - | - |
| Total Current Assets | 465.34 | 369.77 | 209.88 | 298.7 | 39.95 | 17.44 |
| Property, Plant & Equipment | 84.56 | 92.68 | 33.02 | 6.26 | 3.04 | 0.8 |
| Other Long-Term Assets | 4.7 | 6.74 | 9.16 | 0.87 | 0.54 | - |
| Total Assets | 554.59 | 469.19 | 252.06 | 305.83 | 43.53 | 18.24 |
| Accounts Payable | 1.29 | 3.28 | 5.99 | 0.71 | 1.6 | 0.71 |
| Accrued Expenses | 12.43 | 10.32 | 7.15 | 5.53 | 1.64 | 0.99 |
| Current Portion of Leases | 7.74 | 7.91 | 8.41 | - | - | - |
| Current Income Taxes Payable | 2.25 | 4.02 | - | - | - | - |
| Current Unearned Revenue | 45.92 | 132.26 | - | - | - | - |
| Other Current Liabilities | 0.98 | 1 | 0.43 | 0.49 | 0.12 | 0.22 |
| Total Current Liabilities | 70.6 | 158.8 | 21.97 | 6.72 | 3.36 | 1.92 |
| Long-Term Leases | 53.58 | 60.32 | 17.53 | - | - | - |
| Long-Term Unearned Revenue | 7.96 | 7.72 | - | - | - | - |
| Other Long-Term Liabilities | - | - | - | 0.4 | - | 0.02 |
| Total Liabilities | 132.14 | 226.83 | 39.5 | 7.12 | 3.36 | 1.94 |
| Common Stock | 0 | 0 | 0 | 0 | - | 0 |
| Additional Paid-In Capital | 551.95 | 437.13 | 402.89 | 392.38 | 1.02 | 0.47 |
| Retained Earnings | -130.48 | -194.97 | -188.29 | -93.67 | -42.51 | -15.99 |
| Comprehensive Income & Other | 0.97 | 0.2 | -2.06 | - | - | - |
| Total Common Equity | 422.45 | 242.36 | 212.55 | 298.72 | -41.49 | -15.52 |
| Shareholders' Equity | 422.45 | 242.36 | 212.55 | 298.72 | 40.17 | 16.3 |
| Total Liabilities & Equity | 554.59 | 469.19 | 252.06 | 305.83 | 43.53 | 18.24 |
| Total Debt | 61.31 | 68.23 | 25.94 | - | - | - |
| Net Cash (Debt) | 388.03 | 283.74 | 162.78 | 291.06 | 39.05 | 16.84 |
| Net Cash Growth | 36.39% | 74.31% | -44.08% | 645.46% | 131.80% | - |
| Net Cash Per Share | 10.92 | 8.59 | 5.20 | 46.44 | 35.33 | 18.05 |
| Filing Date Shares Outstanding | 35.41 | 32.33 | 33.08 | 31.25 | 1.41 | 0.93 |
| Total Common Shares Outstanding | 35.4 | 32.17 | 31.39 | 31.22 | 1.24 | 0.93 |
| Working Capital | 394.73 | 210.98 | 187.9 | 291.98 | 36.59 | 15.52 |
| Book Value Per Share | 11.93 | 7.53 | 6.77 | 9.57 | -33.35 | -16.63 |
| Tangible Book Value | 422.45 | 242.36 | 212.55 | 298.72 | -41.49 | -15.52 |
| Tangible Book Value Per Share | 11.93 | 7.53 | 6.77 | 9.57 | -33.35 | -16.63 |
| Machinery | 17.32 | 15.26 | 8.54 | 6.12 | 2.16 | 0.85 |
| Construction In Progress | - | - | 0.58 | - | - | - |
| Leasehold Improvements | 1.93 | 1.86 | 1.86 | 1.56 | 1.25 | 0.07 |
Source: S&P Capital IQ. Standard template. Financial Sources.